FDA — authorised 24 May 2002
- Application: NDA021266
- Marketing authorisation holder: PF PRISM CV
- Local brand name: VFEND
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 voriconazole tablet in United States
FDA authorised voriconazole tablet on 24 May 2002
Marketing authorisations
FDA — authorised 24 May 2002
- Application: NDA021267
- Marketing authorisation holder: PF PRISM CV
- Local brand name: VFEND
- Indication: POWDER — INTRAVENOUS
- Status: approved
FDA — authorised 14 November 2003
- Application: NDA021464
- Marketing authorisation holder: PFIZER
- Local brand name: VFEND
- Indication: Tablet — Oral
- Status: approved
FDA — authorised 14 November 2003
- Application: NDA021466
- Marketing authorisation holder: PFIZER
- Local brand name: VFEND
- Indication: Tablet — Oral
- Status: approved
Frequently asked questions
Is voriconazole tablet approved in United States?
Yes. FDA authorised it on 24 May 2002; FDA authorised it on 24 May 2002; FDA authorised it on 14 November 2003.
Who is the marketing authorisation holder for voriconazole tablet in United States?
PF PRISM CV holds the US marketing authorisation.